DOES TUMOR MICROVASCULATURE IMPACT RESPONSE TO BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AGAINST BRAIN TUMOR XENOGRAFTS?
Publication
, Conference
Keir, S; Bigner, D; Friedman, H
Published in: NEURO-ONCOLOGY
May 1, 2011
Duke Scholars
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
May 1, 2011
Volume
13
Start / End Page
I20 / I20
Location
New Orleans, LA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Pediatric Neuro-Oncology Basic and Translational Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Keir, S., Bigner, D., & Friedman, H. (2011). DOES TUMOR MICROVASCULATURE IMPACT RESPONSE TO BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AGAINST BRAIN TUMOR XENOGRAFTS? In NEURO-ONCOLOGY (Vol. 13, pp. I20–I20). New Orleans, LA: OXFORD UNIV PRESS INC.
Keir, Stephen, Darell Bigner, and Henry Friedman. “DOES TUMOR MICROVASCULATURE IMPACT RESPONSE TO BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AGAINST BRAIN TUMOR XENOGRAFTS?” In NEURO-ONCOLOGY, 13:I20–I20. OXFORD UNIV PRESS INC, 2011.
Keir S, Bigner D, Friedman H. DOES TUMOR MICROVASCULATURE IMPACT RESPONSE TO BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AGAINST BRAIN TUMOR XENOGRAFTS? In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2011. p. I20–I20.
Keir, Stephen, et al. “DOES TUMOR MICROVASCULATURE IMPACT RESPONSE TO BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AGAINST BRAIN TUMOR XENOGRAFTS?” NEURO-ONCOLOGY, vol. 13, OXFORD UNIV PRESS INC, 2011, pp. I20–I20.
Keir S, Bigner D, Friedman H. DOES TUMOR MICROVASCULATURE IMPACT RESPONSE TO BEVACIZUMAB IN COMBINATION WITH TEMOZOLOMIDE AGAINST BRAIN TUMOR XENOGRAFTS? NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2011. p. I20–I20.
Published In
NEURO-ONCOLOGY
ISSN
1522-8517
Publication Date
May 1, 2011
Volume
13
Start / End Page
I20 / I20
Location
New Orleans, LA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Pediatric Neuro-Oncology Basic and Translational Research Conference
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences